holomd.ai

What It Is

HoloMD’s core product, Dr. Holo, is an AI agent for psychiatry and mental health care settings, positioned as a “remote therapeutic monitoring companion.” It is not a general-purpose chatbot; rather, it is designed around continuous patient support between visits, treatment response tracking, deterioration alerts, and clinical decision support for physicians. It also emphasizes the potential to generate reimbursable revenue through RTM remote therapeutic monitoring codes.

Core Capabilities and Use Cases

According to the site, Dr. Holo checks in with patients regularly and delivers personalized interactions based on each patient’s medical history, clinical presentation, prior conversations, and new clinical information. Its knowledge base spans psychiatry, brain science, peer-reviewed literature, medical records, and content from clinical experts. It promotes a holistic Root Cause Psychiatry™ approach intended to help identify the underlying causes of mental health issues. Typical use cases include tracking progress in depression treatment, supporting treatment-resistant patients, psychiatric follow-up, clinical decision support, and alerting clinical monitoring teams when a patient’s condition worsens.

Pricing and Business Model

The main content does not disclose specific pricing, subscription plans, trial periods, or deployment costs. What is clearer is the commercial positioning: Dr. Holo is designed to provide reimbursable RTM services and supports automated billing based on RTM codes approved by Medicare, most commercial insurers, and many Medicaid plans. As such, it looks more like a B2B/B2B2C product for healthcare organizations than a self-service mental health app aimed directly at individual consumers.

Privacy, Security, and Integrations

HoloMD explicitly states that its technology complies with HIPAA, HITECH, and related regulations, and that it uses cybersecurity measures to protect interaction data. This is critical for any medical AI product. However, the page does not provide details on APIs, EHR/EMR, FHIR/HL7, electronic medical records, or billing system integrations. It also does not explain more granular compliance arrangements such as data retention, whether patient data is used for model training, or audit mechanisms.

Pros, Cons, and Limitations

Its strengths are a focused use case, a clear healthcare reimbursement path, and endorsement by a founding team with psychiatric expertise. It also emphasizes empathetic companionship, individualized relationships, and alerts for clinical staff, which align well with pain points in continuous mental health care. The main drawback is that the publicly available information remains fairly promotional: it does not disclose the underlying model, clinical validation data, outcome metrics, crisis intervention workflows, false-positive/false-negative rates, or pricing. Mental health is a high-risk domain, and AI output should not replace diagnosis or treatment by a physician.

Who It’s For and Access from China

It is best suited to U.S. psychiatry clinics, mental health organizations, primary care providers, and healthcare service providers interested in RTM billing. The main text does not clarify access, payment, or compliance availability for users in China, so these remain unknown. Deployment in China would also involve local requirements around medical devices, cross-border data transfers, personal information protection, and medical AI compliance. Comparable international alternatives include Woebot Health, Wysa, Limbic, Lyra Health, and others.